Centralized coordination and standardization of electronic health record (EHR) pilot

Ended Awarded Last action

Contract number
75N91021F00011
Awardee
Awarding agency
Obligated
$9,125,386

Award facts

Contract value 100% obligated
$9,125,386.00 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21703, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Terminate for Cause P00004 -$577,878
Supplemental Agreement for work within scope P00003 · EOI:: implementing the presidents department of government efficiency cost efficiency initiative (march 19, 2025)::EOI $0
Other Administrative Action P00002 · This is a no cost bilateral modification to extend the period of performance for to 75N91021F00011 $0
Other Administrative Action P00001 $0
Original award $9,703,264

About this award

This federal contract award, with an ID of 75N91019D00024|75N91021F00011, was issued by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for the "Centralized Coordination and Standardization of Electronic Health Record (EHR) Pilot" and has a ceiling value of $9,125,386.00. It is a cost-plus-fixed-fee type contract with a delivery order pricing structure. The contract does not have a set-aside designation. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor that provides a range of biomedical research and facilities support services to federal agencies, primarily the National Institutes of Health (NIH). This contract supports the NCI's efforts to centralize and standardize EHR systems, which is a critical component of the agency's broader healthcare and informatics initiatives.

Quick answers

Who was awarded contract 75N91021F00011?

75N91021F00011 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2021.

How much is contract 75N91021F00011 worth?

The government has obligated $9,125,386 on 75N91021F00011.

Is contract 75N91021F00011 an order under another contract?

Yes. 75N91021F00011 is a delivery order under 75N91019D00024, an indefinite delivery contract.

Was contract 75N91021F00011 competed?

The extent of competition for 75N91021F00011 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award